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Abstract 
The nuclear receptor coactivator-6 (NCOA6, AIB3, PRIP, ASC-2, TRBP, RAP250 or NRC) is 
a  co-activator  for  nuclear  hormone  receptors  and  certain  other  transcription  factors. 
NCOA6 plays an important role in embryonic development, adipocyte differentiation, me-
tabolism and breast carcinogenesis. The human and mouse NCOA6 genes had 15 and 14 
previously identified exons, respectively. This study further identified an alternatively spliced 
exon 11b (E11b) in human or E10b in mouse, which codes a short polypeptide and a Stop 
codon, resulting in splicing variants lacking the last four exon-coded polypeptide. Analyses of 
mouse  testis  NCOA6  mRNAs  identified  four  alternatively  spliced  variants,  NCOA6- 
(without E10b), - (without E10a and E10b), - (with E10a and E10b) and - (without E10a but 
with E10b). These isoforms were detected in multiple mouse tissues and in MDA-MB-435 
human cells. NCOA6- and - are mainly located in the nucleus; NCOA6- is located in both 
cytoplasm and nucleus; and NCOA6- is mainly located in mitochondria. The C-terminus 
coded by the last four exons was responsible for locating NCOA6- and - into the nucleus. 
The human E11a or mouse E10a-coded region is responsible for distributing NCOA6- in 
both cytoplasm and nucleus, while the region coded by E8-E9 in human or E7-E8 in mouse is 
responsible for directing NCOA6- to mitochondria. Our assays also demonstrated that 
NCOA6- and - could significantly enhance estrogen receptor -mediated transcription, 
but NCOA6- and - were unable to do so. These results suggest that the diverse physio-
logical function of NCOA6 may be mediated by multiple isoforms expressed in different 
tissues and localized in different subcellular compartments. 
Key words: nuclear receptor coactivator-6, NCOA6  
Introduction 
The  nuclear  receptors  (NRs)  are  hor-
mone-inducible  transcription  factors  that  play  im-
portant  roles  in  various  physiological  processes  by 
regulating gene expression. Hormone-activated NRs 
regulate their target genes mainly through recruiting 
coactivators  or  corepressors  to  influence  chromatin 
remodeling and basal transcription factor assembly (1, 
2).  Among many identified NR coregulators, the nu-
clear  receptor  coactivator-6  (NCOA6)  has  many 
unique  biological  functions.  NCOA6  is  an  essential 
coactivator for embryonic development, as knockout 
of the NCOA6 gene in mice results in embryonic le-
thality  accompanied  with  defective  development  of 
placenta,  heart  and  liver  (3-6).  Disruption  of  one 
NCOA6 allele in mice accelerates polyoma middle-T 
antigen-induced mammary tumorigenesis, decreases 
insulin secretion and reduces postnatal growth, sug-
gesting  a  functional  haplodeficiency  of  the  NCOA6 Int. J. Biol. Sci. 2011, 7 
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gene  (6-8).  Furthermore,  specific  deletion  of  the 
NCOA6 gene in mouse mammary epithelial cells de-
creases mammary ductal growth regulated by estro-
gen and partially impairs milk synthesis (9). Moreo-
ver, the NCOA6 gene is amplified and overexpressed 
in subsets of the breast, colon and lung cancers, sug-
gesting its potential role in carcinogenesis (10-16).  
The NCOA6 gene is broadly expressed in many 
tissues (17).  The human  NCOA6 gene (NCBI Gene 
Database, ID 23054) contains 15 exons and codes for 
2063 a.a. residues (18).  The largest Exon 11 is about 3 
kb in length.  The start and stop codons are located in 
exons 3 and 15, respectively.  The mouse NCOA6 gene 
(NCBI  Gene  Database,  ID  56406)  contains  14  exons 
and codes for 2069 a.a. residues. The start and stop 
codons are in exons 2 and 14, respectively.  The 10th 
exon of the mouse NCOA6 gene is corresponding to 
the largest 11th exon of the human NCOA6 gene. The 
NCOA6 protein contains two LXXLL (L, leucine; X, 
any a.a.) motifs that serve as nuclear interaction mo-
tifs.    Ectopic  expression  of  the  dominant  negative 
mutant  containing  the  N-terminal  LXXLL  motif  in 
transgenic  mice,  which  blocks  NCOA6  interaction 
with multiple NRs, causes severe microphthalmia and 
posterior lenticonus with cataract as well as a variety 
of pathophysiological phenotypes in many other or-
gans (19). Interestingly, loss-of-functional mutation of 
the C-terminal LXXLL motif in exon 10 of the mouse 
NCOA6 gene does not affect embryonic development 
and postnatal growth as well as the estrogen receptor 
 (ER) function. Instead, it specifically disturbs the 
liver X receptor  (LXR)-regulated lipogenesis and 
cholesterol/bile acid homeostasis in the liver (20). At 
the  molecular  level,  NCOA6  may  enhance 
NR-dependent  transcription  through  its  interaction 
and  recruitment  of  multiple  coactivator  complexes, 
such as ASC-2 (NCOA6) complex, SRC-1/CBP (ster-
oid  receptor  coactivator-1/cAMP  response  ele-
ment-binding  protein  binding  protein)  complex, 
TRAP (thyroid receptor associated protein) or DRIP 
(vitamin D receptor-interacting protein) complex, and 
COAA (coactivator-associated coactivator) (11-16, 21, 
22).  
Although  there  are  only  about  30,000  pro-
tein-coding genes in the human genome, alternative 
splicing  events  of  mRNAs  and  posttranslational 
modifications markedly increase the total number of 
protein molecules as well as their functional diversi-
ties. Since the NCOA6 gene has a complex structure 
and its protein plays important and diverse biological 
functions  during  development,  organ  function  and 
carcinogenesis, it should be important to explore pos-
sible splicing variants of NCOA6 and their respective 
molecular  and  functional  features.    However,  alt-
hough the existence of a NCOA6 splicing variant has 
been suggested at the mRNA level, NCOA6 isoform 
proteins  generated  from  alternative  splicing  are 
largely unknown.  In this study, we have identified 
four NCOA6 splicing isoforms, examined their in vivo 
expression patterns and characterized their subcellu-
lar localizations and transcriptional activities.  These 
findings  should  provide  molecular  structural  bases 
for understanding the diverse biological function of 
the NCOA6 gene. 
Materials and Methods 
 Plasmid  construction.  The  pcDNA3-TRBP 
(NCOA6)  expression  plasmid  containing  human 
NCOA6-  cDNA  with  a  5’  Flag  tag  was  described 
previously  (13).  The  other  NCOA6  isoform  cDNAs 
and  cDNA  fragments  were  amplified  by  PCR  and 
subcloned  into  the  same  plasmid  by  replacing  the 
NCOA6-  cDNA.  To  express  GFP-NCOA6  fusion 
proteins, NCOA6 cDNA fragments were amplified by 
PCR and ligated to the 3’ GFP coding sequence in the 
pEGFP-C3 plasmid (BD Biosciences Clontech, Moun-
tain View, CA). All newly constructed plasmids were 
verified by DNA sequencing.  
 RT-PCR.  Total RNA was extracted from cells 
and  tissues  using  the  TRIzol  reagent  (Invitrogen, 
Carlsbad, CA). The purified RNA was resuspended in 
RNase-free  water.  RNA  quality  was  estimated  by 
running 1% agarose gel.  RNA samples were treated 
with RNase-free DNase I to remove residual genomic 
DNA. Two g of total RNA was reversely transcribed 
into  cDNA  using  the  SuperScript  II  Reverse  Tran-
scriptase  kit  (Invitrogen,  Carlsbad,  CA).    The  PCR 
primers  used  for  detecting  mouse  NCOA6  splicing 
variants include P16 (CAGAGTGACATTTCTGCAGG), P13 
(ACCCCAGATAATCGTCCAAC),  65F  (CCTCAACAGGACCC 
ATCTTAC),  P23  (CCTTGCAGTGCTGTGGC)  and  3R 
(TCAAGTCATCTTCCAGCTCGC) (Fig. 1A). The GAPDH-F 
(CTGGTCACCAGGGCTGC)  and  GAPDH-R 
(GTGAGTTGTCATATTTCTCGTGG) primers were used for 
detecting GAPDH cDNA, which served as a control. 
The PCR primers used for detecting human NCOA6 
splicing  variants  include  hNCOA6-P1 
(CAGAGTGACATATCTGCAGG) in exon 9, hNCOA6-P1R 
(CTCCAGCTCTGGTCTGGC)  in  exon  12,  hNCOA6-P2F 
(GCAATCATGGTGGCATAGC)  in  exon  11a  and 
hNCOA6-P2R (GCACTCGAGCTTGTTTACTTGGATTTTC) in 
exon 15.  
 Immunocytofluorescence.  Cells  cultured  on 
slide  cover  slips  were  washed  twice  with  PBS  and 
fixed in freshly made 4% paraformaldehyde (pH7.4) 
for 10 minutes on ice. Fixed cells were permeabilized 
in  PBS  containing  0.1%  Triton  X-100  for  5  minutes, 
blocked with 1% BSA in PBS at room temperature for Int. J. Biol. Sci. 2011, 7 
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one hour, and then washed three times with PBS. The 
prepared cells were incubated overnight at 4oC with 
anti-Flag  monoclonal  antibody  at  1:5000  dilution  in 
PBS  with  1%  BSA  (Sigma,  St.  Louis,  MO).  After 
washed 5 times in PBS, the cells were incubated in 
1:200  dilution  of  the  FITC-labeled  goat-anti-mouse 
IgG (Zymed laboratories, South San Francisco, CA), 
washed  twice  in  PBS  and  mounted  in  Vectashield 
mounting  medium  with  DAPI  (Vector,  Burlingame, 
CA). The mitochondrial staining was performed using 
the  MitoTracker  and  MitoFluor  Mitochon-
driaon-Selective  Probes  kit  (Molecular  Probes,  Eu-
gene,  OR)  by  following  the  manufacturer’s  instruc-
tion. 
 Immunoblotting.  Whole  cell  lysate  was  ex-
tracted using RIPA buffer (25 mM Tris-HCl, pH 7.6, 
150  mM  NaCl,  1%  sodium  deoxycholate,  0.1%  SDS 
and 1% NP-40) containing proteinase inhibitor cock-
tail.  Cytosolic  and  nuclear  extracts  were  prepared 
using the NE-PER Nuclear and Cytoplasmic Extrac-
tion Reagents kit (Thermo Fisher Scientific, Rockford, 
IL).  Mitochondrial  extract  was  prepared  using  the 
Mitochondria Isolation Kit for Cultured Cells (Ther-
mo Fisher Scientific, Rockford, IL). Cellular and sub-
cellular  extracts  were  separated  in 
SDS-polyacrylamide gels and blotted onto nitrocellu-
lose  membranes.  The  blots  were  probed  with  indi-
vidual  primary  antibodies  followed  by  appropriate 
secondary  antibodies  conjugated  with  horseradish 
peroxidase (HRP) (BD Biosciences, San Jose, CA). The 
blots  were  developed  using  the  chemiluminescent 
horseradish peroxidase substrate solution (Millipore 
Co., Billerica, MA) for about 5 min and then exposed 
to X-ray films. The primary antibodies included poly-
clonal antibodies against the mouse exons 3-4 (corre-
sponding  to  human  exons  4-5)  coded  region  of 
NCOA6  (7)  and  monoclonal  antibody  against  the 
human  exons  13-15  (corresponding  to  mouse  exons 
12-14) coded region of NCOA6 (provided by Dr. Lee). 
Other primary antibodies included monoclonal anti-
bodies against heat shock protein 90 (Hsp90) (Sigma, 
St. Louis, MO) and voltage-dependent anion-selective 
channel protein 1 (VDAC) (Calbiochem, Gibbstown, 
NJ)  and  polyclonal  antibodies  against 
poly-(ADP-ribose) polymerase (PARP) (Upstate Bio-
technology, Lake Placid, NY). 
 Cell  Culture,  Transient  Transfection  and  Lu-
ciferase  Assay.  Cells  were  cultured  in  Dulbecco’s 
modified  Eagle’s  medium  (DMEM)  containing  10% 
fetal bovine serum (FBS). In subcellular localization 
experiments, Hela cells and NCOA6 null mouse em-
bryonic fibroblasts were transiently transfected with 
plasmids for expressing Flag-tagged NCOA6 isoforms 
and  mutants  or  with  plasmids  for  expressing 
GFP-NCOA6  fusion  proteins.  Cells  expressing 
Flag-tagged proteins were analyzed by immunocyto-
fluorescence, while  live cells expressing  GFP fusion 
proteins were analyzed by green fluorescent micros-
copy. To measure the coactivator activities of NCOA6 
isoforms, Hela cells were cultured in 24-well plates in 
phenol  red-free  medium  containing  5%  of  char-
coal-stripped  FBS  and  transfected  with  plasmid 
DNAs using Lipofectamine 2000 reagent (Invitrogen, 
Carlsbad, CA). Specifically, cells were co-transfected 
with RSV-ER (0.2 g) plasmids for ER expression, 
ERE-tk-Luc  plasmids  (0.2  g)  for  reporting 
ER-dependent  transcription,  RSV--galacrosidase 
expression  plasmids  (0.1  g)  for  normalizing  trans-
fectional efficiency and one of the pcDNA3-NCOA6 
expression plasmids (0.3 g of pcDNA-NCOA6-, ,  
or  ).  Transfected  cells  were  treated  with  10-8  M  of 
17-estradiol  for  24  hours,  and  then  harvested  and 
extracted with the cell lysis buffer in a Luciferase As-
say Kit (Promega, Madison, WI). Luciferase activity in 
the cell lysates was assayed using the same kit. The 
-galactosidase  activity  was  assayed  using  the 
Mammalian  -Galactosidase  Assay  Kit  (Thermo 
Fisher Scientific, Rochford, IL). The luciferase activity 
was normalized to the -galactosidase activity in the 
same sample to represent the relative ER transcrip-
tional  activity  enhanced  by  individual  NCOA6 
isoforms.  
Results 
Alternative Splicing of the NCOA6 RNA Creates 
Four Isoforms 
 Several  species  of  NCOA6  mRNAs  have  been 
detected  in  multiple  human  and  mouse  tissues  by 
Northern blot in previous studies, suggesting the ex-
istence  of  multiple  alternative  splicing  variants  of 
NCOA6  in vivo  (14,  15).  Indeed,  in  addition  to  the 
full-length NCOA6-, an alternative splicing variant, 
NCOA6- has been identified at its mRNA level from 
human  testis  (14).  In  comparison  with  human 
NCOA6- with 2063 amino acids, human NCOA6- 
isoform  only  contains  1070  amino  acids  (1-971  and 
1965-2063), which is resulted from skipping over the 
largest 11th exon of the human NCOA6 gene (14). The 
mouse NCOA6 gene contains 14 exons, and its largest 
10th  exon  is  about  3  kb  in  length  (20).  To  examine 
whether  the  NCOA6-  isoform  was  also  present  in 
mouse, we isolated RNA from the mouse testis and 
performed  RT-PCR  using  several  pairs  of  primers 
spanning  exons  8–14  (Fig.  1A).  As  predicted,  the 
NCOA6-  isoform  was  detected  by  primer  pairs 
65F/P23  and  65F/3R,  exhibiting  as  a  248-bp  and  a 
520-bp bands, respectively (Fig. 1B, the lower bands in Int. J. Biol. Sci. 2011, 7 
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the indicated lanes). The NCOA6- isoform without 
exon 10 was detected by primer pairs P16/P23 (298 
bp), P13/P23 (172 bp), P16/3R (570 bp) and P13/3R 
(444 bp), respectively (Fig. 1B, the lower bands in the 
indicated  lanes).  Surprisingly,  each  of  the  above 
RT-PCR reactions detected a higher band in addition 
to the expected NCOA6- or  band. Sequence analy-
sis of these higher bands identified a 110-bp insertion 
sequence in all of these longer RT-PCR products, and 
sequence alignment analysis matched this sequence to 
a region of “intron 10” (Fig. 1C). Similar assays using 
RNA  isolated  from  the  MDA-MB-435  human  cells 
also detected a 75-bp insertion sequence correspond-
ing  to  the  similar  “intron  region”  in  the  human 
NCOA6 gene (Fig. 1C). These results indicate that the 
initially designated “intron 10 or 11” of the mouse or 
human NCOA6 gene actually contains a small exon, 
which now can be designated as exon 10b (E10b) in 
mouse or exon 11b (E11b) in human. Accordingly, the 
formerly  named  mouse  E10  or  human  E11  can  be 
re-named as E10a or E11a (Fig. 1A and D).   
 
Fig. 1. Identification of NCOA6 splicing isoforms.  A. A part of the mouse NCOA6 gene structure from exon 8 to 
exon 14. The boxes represent exons. The arrows indicate the locations and directions of the PCR primers.  B. Predicted 
lengths of PCR product from the indicated PCR primer pairs (left panel) and the RT-PCR products amplified from the 
NCOA6 mRNA of mouse testis using the indicated PCR primer pairs. The alternative splicing isoforms identified from the 
upper and lower bands in each lane are labeled below the gel image.  C. The DNA sequence of mouse exon 10b and human 
exon 11b in capital letters and its 5’ and 3’ intron sequences in small letters at the splicing junctions. Stop codons are 
italicized. n.t., nucleotide sequences; a.a., amino acid sequences coded by exon 10a in mouse and 11a in human.  D. Diagram 
of the four NCOA6 isoforms derived from alternate splicing of human exons 11a and 11b (left panel). The lengths of coding 
nucleotides and a.a. residues as well as calculated molecular masses of individual isoforms are summarized in the right panel. 
GenBank accession numbers: JF707634 – JF707639. 
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Both mouse E10b and human E11b are flanked 
with  consensus  RNA  splicing  sites  and  contain  re-
spective TGA and TAA stop codons (Fig. 1C). Before 
these stop codons, the  mouse E10b or human E11b 
encodes for 4 or 11 a.a. residues (Fig. 1C). Therefore, 
the splicing variants with mouse E10b or human E11b 
should  not  have  the  polypeptide  coded  by  the  last 
four exons in both mouse and human NCOA6 genes 
(Fig. 1D). As detected by RT-PCR, either inclusion or 
exclusion of human E11a and/or E11b during RNA 
splicing generated four NCOA6 isoforms, designated 
as  NCOA6-(without  E11b),    (without  E11a  and 
E11b),  (with E11a and E11b) and  (without E11a, 
but  with  E11b)  (Fig.  1D).  The  predicted  lengths  of 
mRNA  coding  regions  and  amino  acids  as  well  as 
calculated molecular masses according to the amino 
acid  compositions  of  human  NCOA6  are  listed  in 
Figure 1D.  
In Vivo Expression of the NCOA6 mRNAs and 
Protein Isoforms  
 To examine the expression patterns of NCOA6 
splicing  isoforms  in vivo, we  isolated  RNA  samples 
from different mouse organs and performed RT-PCR 
with isoform-specific primer pairs. NCOA6- mRNA 
was detected in all organs examined by primers 65F in 
E10a and P23 in E11. Although NCOA6- mRNA was 
also detected in all organs examined by primers P16 in 
E8 and P23, its expression levels were relatively high 
in the testis, ovary, kidney, lung and heart but low in 
the skeletal muscle and uterus (Fig. 2A). Only very 
low levels of NCOA6- mRNA was detected in the 
testis,  cerebellum,  liver  and  skeletal  muscle  by  pri-
mers 65F and P23, while NCOA6- mRNA was only 
detected in the testis by primers P16 and P23 (Fig. 2A).  
These results suggest that NCOA6 isoforms are ex-
pressed in a tissue-specific manner. 
 Next,  we  analyzed  the  expression  patterns  of 
NCOA6  isoform  mRNAs  in  the  mouse  mammary 
glands at different developmental stages. We found 
that the NCOA6- mRNA was expressed in all stages 
including adult virgin, day 18 pregnant, day 15 lacta-
tion and day 3 involution mammary glands of female 
mice (Fig. 2B). The NCOA6- mRNA was expressed at 
a low level in the virgin mouse mammary gland, but 
its  level  was  markedly  increased  in  the  mammary 
glands of pregnant and lactation mice. At involution 
day  3,  the  NCOA6-  mRNA  was  barely  detectable 
(Fig.  2B).  However,  only  low  levels  of  NCOA6- 
mRNA could be detected in the virgin and involution 
mouse mammary glands (Fig. 2B). These results sug-
gest  that  NCOA6  isoforms  are  expressed  in  the 
mammary  gland  in  a  developmental  stage-specific 
manner.  
 
 
Fig. 2. Expression of the NCOA6 isoforms in mouse 
tissues.    A. Detection of NCOA6 mRNAs in different 
mouse  organs  by  RT-PCR.  GAPDH  (glyceralde-
hyde-3-phosphate  dehydrogenase)  RT-PCR  products 
served as an endogenous control.  B. Analysis of NCOA6 
isoform mRNA levels by RT-PCR in the mouse mammary 
glands at different developmental stages.  Vir, P18, L15 and 
In3, mammary glands from virgin, pregnant day 18, lactation 
day 15 and involution day 3 female mice, respectively.  C. 
Western blot analysis of mouse testis tissue extracts using 
antibodies against NCOA6 peptide regions coded by mouse 
exons 3-4 and exons 12-14, respectively.  
 
 
 NCOA6  isoform  proteins  were  analyzed  by 
Western  blot  using  polyclonal  antibodies  generated 
from recombinant polypeptides encoded by specific 
exons. All four isoforms were detected in the mouse 
testis tissue extract by Western blot using a polyclonal 
antibody  against  a  common  N-terminal  region  en-
coded  by  mouse  exons  3  and  4.  Among  these 
isoforms,  NCOA6-  and  NCOA6-  protein  levels 
were much higher than NCOA6- and  protein levels 
(Fig. 2C, lane 1). On the other hand, NCOA6- and  
isoforms were detected in the same tissue extract by 
Western blot using a monoclonal antibody against a 
C-terminal region coded by mouse exons 12-14, a re-
gion  in  NCOA6-  and    but  not  in  the  other  two 
isoforms  (Fig.  2C,  lane  2).  It  was  noticed  that  the 
C-terminal  antibody  detected  a  strong  NCOA6- Int. J. Biol. Sci. 2011, 7 
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band but a weak NCOA6- band, which was probably 
caused  by  a  limited  access  of  this  antibody  to  the 
C-terminus  of  the  NCOA6-  isoform  since  the 
NCOA6- and NCOA6- isoforms showed compara-
ble band intensities as assayed by the N-terminal an-
tibody (Fig. 2C, compare lanes 1 and 2). These results 
demonstrated that all four NCOA6 isoform proteins 
are expressed in vivo, while NCOA6- and  are major 
isoforms expressed in the testis. 
Subcellular localizations of the NCOA6 isoforms 
 GFP fusion proteins were expressed in Hela and 
NCOA6 null MEF cells to investigate the subcellular 
localizations  of  the  NCOA6  isoforms.  Fluorescent 
microscopy revealed that GFP was distributed in the 
entire  cells.  GFP-NCOA6-  and  -  fusion  proteins 
were mainly located in the nuclei of both Hela and 
NCOA6 null MEF cells. However, GFP-NCOA6- was 
found in both cytosol and nucleus and GFP-NCOA6- 
was distributed in the cytoplasm as granules (Fig. 3A). 
To  validate  these  observations,  we  also  expressed 
Flag-tagged  NCOA6  isoforms  in  Hela  and  NCOA6 
null  MEF  cells  and  performed  immunocytofluores-
cence  staining.  The  immunostaining  signals  of 
Flag-tagged NCOA6- and - were located in the nu-
cleus,  the  NCOA6-  signal  was  in  the  entire  cells, 
while the NCOA6- signal was scattered in the cyto-
plasm as granules (Fig. 3B). Since the cytoplastic dis-
tribution of NCOA6- showed a granular pattern, we 
expressed  GFP-NCOA6-  in  Hela  and  NCOA6  null 
MEF  cells  and  stained  mitochondria  with  a  mito-
chondrial  tracker  dye.  We  found  that  most  of  the 
GFP-NCOA6-  signals  were  overlapping  with  the 
mitochondrial signals (Fig. 3C). Taken together, these 
results  demonstrated  that  NCOA6-  and  -  are 
mainly located in the nucleus, NCOA6- is located in 
both cytoplasm and nucleus, and NCOA6- is located 
in  the  cytoplasm  with  a  large  portion  in  the  mito-
chondria. 
Identification of the Sequences Responsible for 
the Different Subcellular Localizations of the 
NCOA6 Isoforms.  
 In order to map the specific regions of NCOA6 
responsible  for  nuclear  translocalization,  we  con-
structed a series of Flag-tagged deletion constructs of 
human  NCOA6  isoforms  and  expressed  these 
NCOA6 protein fragments in both Hela and NCOA6 
null  MEF  cells  (Fig.  4A).  Immunostaining  analysis 
revealed that the NCOA6-n8, -n8 and -n8 de-
letion mutants lacking the N-terminal 558 a.a. (exons 
3-8) and the NCOA6-n9, -n9 and -n9 deletion 
mutants  lacking  the  N-terminal  931  a.a. (exons  3-9) 
exhibited  similar  subcellular  localizations  as  their 
corresponding  full-length  NCOA6-,  -  and  - 
isoforms in Hela cells.  Specifically, the  and  dele-
tion mutants were located in the nucleus and  dele-
tion mutants were located in both cytoplasm and nu-
cleus  (Fig.  4B).    These  results  indicate  that  the 
N-terminus of these three isoforms is not essential for 
determining their subcellular localizations. 
 However, the NCOA6-n8 and -n9 proteins 
were distributed in the entire cells, which was differ-
ent  from  the  mitochondrial  localization  of  the 
full-length  NCOA6-  (Fig.  4B).  Interestingly, 
NCOA6-n3-9 (exons 3-9) with the N-terminal 931 a.a. 
showed  a  mitochondrial  localization  similar  to 
NCOA6-,  while  NCOA6-n3-8  (exons  3-8)  with  the 
N-terminal 558 a.a. had a larger portion in the entire 
cytoplasm  versus  the  mitochondrial  distribution  of 
NCOA6-n3-9 (Fig. 4B). The e9 (exon 9)-coded poly-
peptide  was  mainly  located  in  the  perinuclear  area 
and  the  nuclear  membrane  (Fig.  4B).  These  results 
suggest  that  the  region  of  558-931  a.a.  polypeptide 
coded by exon 9 plays an important but insufficient 
role in direction of NCOA6- to the mitochondrium, 
and both E8 and E9-coded regions may be involved in 
efficient  localization  of  NCOA6-  to  the  mitochon-
drium.  
 NCOA6-  contains  984  a.a.  residues  coded  by 
the  largest  human  E11a  that  does  not  exist  in 
NCOA6- and -, but does not have the 98 a.a. resi-
dues coded by E12-E15 that exists in NCOA6- and - 
(Fig.  4A).  Based  on  the  subcellular  localizations  of 
NCOA6- and - in the nucleus and - in both cyto-
plasm  and  nucleus,  we  hypothesized  that  the 
C-terminal  98  a.a.  polypeptide  coded  by  E12-E15 
contains  nuclear  localization  sequence  and  the 
E11a-coded polypeptide can partially translocate into 
the nucleus as NCOA6- does. Indeed, the E11a-coded 
984 a.a. polypeptide was observed in both cytoplasm 
and nucleus and the C-terminal 98 a.a. polypeptide 
was observed in the nucleus in both Hela and MEF 
cells (Fig. 4B). 
 Furthermore,  we  made  GFP  fusion  constructs 
for  all  of  the  deletion  mutants  of  NCOA6  isoforms 
described above (Fig. 4A) and expressed these GFP 
fusion proteins in both Hela and NCOA6 null MEF 
cells. Fluorescent microscopy analysis of GFP signals 
in these live cells demonstrated identical subcellular 
distribution  patterns  of  these  GFP-fused  deletion 
mutants  of  NCOA6  isoforms  to  those  Flag-tagged 
isoforms described above (Fig. 4C). 
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Fig. 3. Subcellular locations of NCOA6 
isoforms.  A.  Subcellular  localizations  of 
GFP-fused hNCOA6 isoforms in transfected 
Hela and NCOA6 null MEF cells. Live cell 
images were taken by GFP fluorescent mi-
croscopy  (left  column)  and  diachronic  in 
contrast  image  (DIC)  microscopy  (central 
column). The merged images are also shown 
(right column).  B. Subcellular locations of 
Flag-tagged hNCOA6 isoforms in Hela and 
NCOA6 null MEF cells. FITC (green) signals 
indicate  the  cellular  locations  of  the 
Flag-tagged  hNCOA6  isoforms.  DAPI 
staining indicates the cell nuclei.  C. Hela 
cells  and  NCOA6  null  MEF  cells  were 
transfected  with  GFP, 
GFP-hNCOA6-e13-15 or GFP-hNCOA6- 
expression plasmid.  Cells were stained with 
mitochondrial tracker (red color) and ex-
amined by fluorescent and DIC microscopy. 
Merged  images  of  GFP  and  mitochondrial 
(Mit) staining as well as GFP and DIC are 
shown. Int. J. Biol. Sci. 2011, 7 
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Fig. 4. Identification of NCOA6 isoform sequences responsible for their subcellular localizations.  A. Diagram 
showing a.a. sequences of hNCOA6- and - coded by specific exons, as well as all other constructed and expressed isoform 
fragments used in  mapping the regions responsible for their subcellular localizations.   B.  Subcellular localizations of 
Flag-tagged hNCOA6 isoform fragments (green) in transfected Hela and NCOA6 null MEF cells. Cell nuclei were stained 
with DAPI.  C. Subcellular localizations of GFP-fused hNCOA6 isoform fragments. 
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 Moreover,  we  prepared  cytoplasmic  fractions 
and nuclear extracts from Hela cells transfected with 
Flag-tagged NCOA6 isoforms and performed West-
ern blot analysis. The high quality of the preparations 
was confirmed by checking the PARP1 nuclear pro-
tein and the Hsp90 cytoplasmic protein (Fig. 5). In the 
first  experiment,  although  the  NCOA6-  and   
isoforms were undetectable due to insufficient DNA 
inputs in the transfection, NCOA6- was solely de-
tected in the nuclear extract (Fig. 5A).  In the second 
experiment  with  enhanced  expression  of  both 
NCOA6- and - in Hela cells, all of the NCOA6- 
protein and most of the NCOA6- protein were de-
tected  in  the  nucleus,  while  a  small  portion  of 
NCOA6-  was  seen  in  the  cytoplasmic  fraction, 
probably due to its over production (Fig. 5B). In the 
third  experiment  with  enhanced  NCOA6-  expres-
sion,  NCOA6-  protein  was  detected  in  both  cyto-
plasmic and nuclear fractions (Fig. 5C). In agreement 
with  the  subcellular  localizations  of  NCOA6-,  its 
fragment (a.a. 982-1965) coded by human E11a was 
also  detected  in  both  cytoplasmic  and  nuclear  frac-
tions  (Fig.  5A).  Interestingly,  the  NCOA6-  protein 
was repeatedly detected in both the cytoplasmic (20%) 
and the nuclear (80%) fractions when samples were 
prepared using a cytoplasmic and nuclear extraction 
kit (Fig. 5A and 5C). However, examination of VDAC, 
a mitochondrial protein marker, revealed that these 
nuclear fractions were contaminated by mitochondri-
al  proteins  (Fig.  5C).  Thereafter,  we  purified  mito-
chondria and measured the amount of NCOA6- in 
the  mitochondrial  extract  with  minimal  PARP1  nu-
clear and Hsp90 cytosol protein contaminations (Fig. 
5D). Indeed, we found abundant NCOA6- protein in 
the  purified  mitochondrial  extract  (Fig.  5D).  These 
results are consistent with the conclusions made from 
the fluorescent microscopic analyses. 
 
 
Fig. 5. Distribution of NCOA6 isoform proteins in subcellular extracts.  A. Transfected Hela cells expressing the 
indicated Flag-tagged hNCOA6 isoforms or human exon 11a-coded peptide (11a) were subjected to preparation of cyto-
plasmic (C) and nuclear (N) fractions, followed by Western blot analysis with antibodies against Flag-tagged isoforms, PARP1 
(a nuclear protein control) and Hsp90 (a cytosolic protein control).  B. Western blot analysis of another batch of cytosolic 
and nuclear fractions prepared from Hela cells transfected with more plasmid DNA versus panel A.  C. Western blot 
analysis of cytosolic and nuclear fractions prepared from Hela cells expressing NCOA6- and - proteins. VDAC served as 
a mitochondrial protein control.  D. Western blot analysis of total lysate (T) and purified mitochondrial (Mi) extract of Hela 
cells transfected with NCOA6-. Int. J. Biol. Sci. 2011, 7 
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Different Activities of the NCOA6 Isoforms in 
Mediating Estrogen Receptor-dependent Tran-
scriptional Activation 
 NCOA6- is an established coactivator for ER 
(12, 20). To measure the coactivator activities of the 
NCOA6 isoforms, we co-transfected Hela cells with 
ER,  ERE-tk-Luc  reporter  and  one  of  the  NCOA6 
isoform expression plasmids. The cells were treated 
with  or  without  17-estradiol.  The  reporter  activity 
assays revealed that NCOA6- and - isoforms sig-
nificantly  enhanced  ER-mediated  transcriptional 
activation, while NCOA6- and - isoforms were in-
capable  to  co-activate  ER-mediated  transcription 
(Fig. 6).  
 
 
 
Fig. 6. Assessment of the coactivator activities of 
the NCOA6 isoforms.  Hela cells were co-transfected 
with ER, ERE-tk-Luc reporter and one of the NCOA6 
isoform expression plasmids or a mock plasmid as indicated. 
A  -galactosidase  expression  vector  was  also 
co-transfected as an internal control.  Cells were treated 
with either 17-estradiol or its vehicle (ethanol) and sub-
jected to luciferase and -galactosidase activity assays. The 
luciferase  activity  was  normalized  to  the  -galactosidase 
activity. *, P < 0.05 by unpaired t test. 
 
Discussion 
In  this  study,  we  found  that  both  human  and 
mouse NCOA6 genes contain two alternative exons, 
the  11a  and  11b  in  human  and  the  10a  and  10b  in 
mouse. Alternative splicing events of these exons re-
sulted  in  endogenously  expressed  four  isoforms, 
NCOA6-, -, - and -. Because the human exon 11b 
or mouse 10b contains a stop codon,  the NCOA6- 
and - isoforms with this exon lack the a.a. sequence 
coded  by  the  last  four  exons  in  both  human  and 
mouse  NCOA6  genes,  while  the  NCOA6-  and  - 
isoforms without this exon contain the common se-
quence coded by the last four exons. Importantly, a 
previously unknown strong nuclear localization sig-
nal was mapped to the C-terminal sequence coded by 
the last four exons in both NCOA6- and - isoforms. 
This nuclear localization region plays a dominant role 
to direct NCOA6- and - to the nucleus. The lack of 
this region in NCOA6- and - provides an explana-
tion for their different subcellular localizations from 
the other two isoforms. We found that NCOA6- is 
distributed  in  both  cytoplasm  and  nucleus,  which 
may  be  determined  by  a  weak  nuclear  localization 
signal residing in the region coded by human E11a 
(a.a. 982-1965) or mouse E10a.  NCOA6- is mainly 
located  in  the  mitochondrium,  and  the  responsible 
region for this localization  is within the N-terminal 
931 a.a. residues of the human protein. Most likely, 
this region is coded by E8 and E9 in human or E7 and 
E8 in mouse.   
 Since the mitochondrial localization sequence is 
common in all isoforms, an intriguing question is why 
other isoforms except NCOA6- do not go to the mi-
tochondrium. Two possibilities might be speculated. 
First, the region coded by the largest E11a in human 
or E10a in mouse in NCOA6- and - may inhibit the 
mitochondrial  localization  signal  in  these  two 
isoforms.  Second,  the  strong  C-terminal  nuclear  lo-
calization  sequence  in  NCOA6-  and  -  plays  a 
dominant role to direct these two isoforms to the nu-
cleus.  Another  mystery  is  that  preliminary  analysis 
failed to locate any typical putative sequence of nu-
clear localization signal in the two mapped regions 
containing  nuclear  localization  functions.  Thus,  the 
minimal nuclear localization domains of NCOA6 re-
main to be determined.  
 A transcriptional coactivator must locate in the 
nucleus  to  coactivate  transcription  factor-regulated 
nuclear gene transcription.  In agreement with their 
nuclear  location,  NCOA6-  and  -  isoforms  can 
strongly potentiate the ER-dependent transcription-
al activation. In contrast, the other two isoforms failed 
to coactivate ER-mediated gene transcription. Since 
NCOA6- is mainly located in the mitochondrium, its 
incapability  to  coactivate  ER  should  be  expected. 
However, NCOA6- is located in both cytoplasm and 
nucleus, but it is also incapable to serve as an ER 
coactivator in the nucleus. These data suggest that the 
C-terminal 98 a.a. residues in NCOA6- and - but 
not in NCOA6- plays important roles in both nuclear 
localization  and  transcriptional  activation.  Previous 
studies have found that the C-terminus of NCOA6- Int. J. Biol. Sci. 2011, 7 
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serves  as  a  part  of  the  interactive  domains  for 
DRIP130, DNA-dependent protein kinase C, CBP and 
CoAA (reviewed in (16)). Thus, it is possible that the 
lack of this region in NCOA6- may make this isoform 
incapable  to  interact  with  some  of  these  factors  re-
quired for transcriptional activation.  
 The presence of four NCOA6 isoforms should 
largely increase functional diversity and specificity of 
the  NCOA6  gene  products.  For  example,  NCOA6- 
does not contain the second LXXLL motif and should 
not interact with LXR in the liver since this LXXLL 
motif specifically interacts with LXR (23). Therefore, 
the previously observed phenotypes in mice with the 
mutated second LXXLL motif should be attributed to 
an impaired function of  NCOA6- for LXR  (20). In 
addition, it would be very interesting to find out what 
NCOA6- and - isoforms do in the cytosol and mi-
tochondrium  in  the  future.  Recent  studies  have 
demonstrated that nuclear receptor coregulators and 
their isoforms may also play important functions in 
the cytoplasm  in addition to their  nuclear function. 
For  example,  the  steroid  receptor  coactivator-3 
(SRC-3) and its splicing variant SRC-34 in the cyto-
plasm can suppress the translation of proinflamma-
tory cytokine mRNAs and bridge epidermal growth 
factor  receptor  (EGFR)-mediated  activation  of  focal 
adhesion kinase, respectively (24, 25). 
 The  detection  of  all  four  NCOA6  isoforms  in 
human  cells  and  mouse  tissues  indicate  that  these 
isoforms may play important roles in vivo. In mice, we 
found that NCOA6- and - are broadly expressed at 
relatively  high  levels  in  different  tissues,  while 
NCOA6- and - are expressed at relatively low levels 
in selective tissues, such as testis and/or mammary 
gland. More interestingly, the expression of NCOA6- 
mRNA is low in the mammary glands of virgin and 
involution day 3 female mice but high in the mam-
mary glands of pregnant and lactation female mice.  
These findings suggest that the diverse physiological 
function of the NCOA6 gene is mediated by multiple 
isoforms that are dynamically expressed in different 
tissues at different developmental stages. 
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